Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680992 · ClinicalTrials.gov registry record · Phase 2
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
A Phase 2 study, sponsored by Amgen.
- Completed
- Registry status
- Phase 2
- Development phase
- 535
- Enrollment target
NCT00680992 is a Phase 2 study that has completed, run by Amgen. The registered enrollment target is 535 participants.
The verdict
NCT00680992, a Phase 2 study, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 535 participants
- Enrollment target
Study Summary
To determine how safe denosumab is in treating subjects with giant cell tumor of bone (GCTB)
Interventions
- DRUG Denosumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 535 participants |
| Start Date | 2008-09-09 |
| Est. Completion | 2018-05-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680992
The ClinicalTrials.gov registry entry for NCT00680992 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 535 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Denosumab is the first listed.
NCT00680992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680992 about?
NCT00680992 is a clinical study titled "Study of Denosumab in Subjects With Giant Cell Tumor of Bone". To determine how safe denosumab is in treating subjects with giant cell tumor of bone (GCTB)
What is the current status of trial NCT00680992?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 535 participants. The study started on 2008-09-09. Estimated completion is 2018-05-17.
What interventions are being tested in trial NCT00680992?
The interventions under investigation include: Denosumab (DRUG).
Who is sponsoring clinical trial NCT00680992?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.